Hemetron AG

Hemetron AG is transforming chronic disease management with its remote blood testing platform. Our hand-held device enables patients with inflammatory rheumatic diseases and other chronic conditions to perform laboratory-grade blood tests at home, with results sent digitally to their physicians for timely treatment adjustments.

By closing the gap between infrequent clinical visits and real-time disease monitoring, we help improve outcomes and reduce healthcare costs. Our initial focus is on rheumatology, and we plan to expand to additional biomarkers and disease areas.

We are shaping a future where everyone, from physicians to patients to health enthusiasts, can act on real-time health insights to effectively combat and prevent chronic diseases.